Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor Inhibitors as Anti-Angiogenic Agents in Cancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 2212-3970|2|1|59-71

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.2, Iss.1, 2007-01, pp. : 59-71

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Vascular Endothelial Growth Factor (VEGF) for Anti-tumor Therapy, by Anti-VEGF Neutralizing Monoclonal Antibodies or by VEGF Receptor Tyrosine-kinase Inhibitors

By Schlaeppi J-M.

Cancer and Metastasis Reviews, Vol. 18, Iss. 4, 1999-12 ,pp. : 473-481

Springer Publishing Company

Access to resources Recommend Favorite

Effects of combination anti-vascular endothelial growth factor receptor and anti-epidermal growth factor receptor therapies on the growth of gastric cancer in a nude mouse model

By Jung Y.D. Mansfield P.F. Akagi M. Takeda A. Liu W. Bucana C.D. Hicklin D.J. Ellis L.M.

European Journal of Cancer, Vol. 38, Iss. 8, 2002-05 ,pp. : 1133-1140

Elsevier

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor Antagonists as Anticancer Agents

By Jurjees Hasan Gordon C. Jayson

American Journal of Cancer, Vol. 3, Iss. 4, 2004-01 ,pp. : 229-245

Adis International

Access to resources Recommend Favorite

Vascular endothelial growth factor inhibitors in malignant gliomas

By Brastianos Priscilla

Targeted Oncology, Vol. 5, Iss. 3, 2010-09 ,pp. : 167-174

Springer Publishing Company

Access to resources Recommend Favorite

Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancer

By Yonemura Y. Fushida S. Bando E. Kinoshita K. Miwa K. Endo Y. Sugiyama K. Partanen T. Yamamoto H. Sasaki T.

European Journal of Cancer, Vol. 37, Iss. 7, 2001-05 ,pp. : 918-923

Elsevier

Access to resources Recommend Favorite